Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) EBIT Margin (2019 - 2025)

Volitionrx filings provide 8 years of EBIT Margin readings, the most recent being 127774.7% for Q4 2025.

  • On a quarterly basis, EBIT Margin rose 11192716.0% to 127774.7% in Q4 2025 year-over-year; TTM through Dec 2025 was 1830.36%, a 105403.0% increase, with the full-year FY2025 number at 1702.88%, up 98518.0% from a year prior.
  • EBIT Margin hit 127774.7% in Q4 2025 for Volitionrx, up from 947.47% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 127774.7% in Q4 2025 to a low of 61692.56% in Q4 2021.
  • Median EBIT Margin over the past 5 years was 5062.75% (2024), compared with a mean of 4286.07%.
  • Biggest five-year swings in EBIT Margin: skyrocketed 190771026bps in 2021 and later surged 21760bps in 2025.
  • Volitionrx's EBIT Margin stood at 61692.56% in 2021, then skyrocketed by 89bps to 6691.45% in 2022, then skyrocketed by 46bps to 3582.6% in 2023, then soared by 542bps to 15847.54% in 2024, then soared by 706bps to 127774.7% in 2025.
  • The last three reported values for EBIT Margin were 127774.7% (Q4 2025), 947.47% (Q3 2025), and 1548.56% (Q2 2025) per Business Quant data.